Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion

NCT06029998 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
22
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Utah